Active Ingredient: VIMSELTINIB
Proprietary Name: ROMVIMZA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 30MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N219304
Product Number: 003
Approval Date: Feb 14, 2025
Applicant Holder Full Name: DECIPHERA PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information